About this trial
This study examines the impact of intraoperative recurrent laryngeal nerve monitoring signal changes on the postoperative voice quality of thyroid surgery patients. By analyzing extensive surgical data and postoperative voice recordings, the investigation seeks to identify patterns in the variations of these signals and their correlation with voice quality outcomes. The goal is to enhance clinical understanding and surgical practices, allowing for more precise assessments of nerve function, informed surgical interventions, and improved postoperative patient well-being.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 20-60 years old.
Planned conventional unilateral thyroid lobectomy + isthmus resection + central compartment lymph node dissection.
Disqualifiers
History of past head and neck surgeries.
Pronunciation system defect and disorder history.
History of vocal cord polyps or nodules.
History of upper respiratory tract infection in the 2 weeks before surgery or postoperative infection history.
Trial population
People with thyroid cancer who are planned to undergo traditional surgical treatment.
Trial design
Cohort
Prospective
Treatments tested in this trial
Traditional thyroid surgery.
Procedure/SurgeryThe patient undergoes traditional thyroid surgery with concurrent intraoperative nerve monitoring technology.
Treatment groups
Trial outcomes
Primary outcomes
Intraoperative electromyographic signals.
Recording intraoperative electromyographic signals, including vagus nerve V1 and V2 signals, recurrent laryngeal nerve R1 and R2 signals.
Voice analysis data(SPL)
Recording data(SPL) of voice tests before and after the surgery, sound pressure level in dB(A)
Voice analysis data(F0)
Recording data(F0) of voice tests before and after the surgery, F0 in Hz
Voice analysis data(Jitter)
Recording data(Jitter) of voice tests before and after the surgery, Jitter in percentage
Secondary outcomes
RBH
Conducted by an otolaryngologist, the RBH assessment includes R (Roughness), B (Breathiness), and H (Hoarseness).
VHI-30
Voice Handicap Index, including a scale with 30 items.The full, non-abbreviated title of the VHI-30 scale is the "Voice Handicap Index-30," and it is translated as the "Voice Disorder Severity Index." The scale ranges from a minimum score of 0 to a maximum of 120, with higher scores indicating poorer outcomes.
Neural Width
Recorded width of the recurrent laryngeal nerve in millimeters.
Is there branching
Note if the recurrent laryngeal nerve branches.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.